Occipital neuralgia generally responds to medical or invasive procedures. Repeated invasive procedures generate increasing complications and are often contraindicated. Stereotactic radiosurgery (SRS) has not been reported as a treatment option largely due to the extracranial nature of the target as opposed to the similar, more established trigeminal neuralgia. A dedicated phantom study was conducted to determine the optimum imaging studies, fusion matrices, and treatment planning parameters to target the C2 dorsal root ganglion which forms the occipital nerve. The conditions created from the phantom were 
| INTRODUCTION
Occipital neuralgia is a neurological condition characterized by paroxysms of intense pain transmitted by the greater occipital nerves in the back of the head and neck often accompanied by a dull ache. [1] [2] [3] [4] The condition is differentially diagnosed from other headache types by using patient descriptions of the pain, noting the location of tenderness associated with pain episodes, and achieving prompt relief of pain following an anesthetic block of the greater occipital nerve. 5, 6 The incidence of occipital neuralgia in the general population remains unknown but is thought to be less than that of trigeminal neuralgia and glossopharyngeal neuralgia which have an incidence of 20/ 100,000 per year and 0.7/100,000 per year, respectively. 7 Medical management for patients diagnosed with occipital neuralgia generally includes analgesics or anti-inflammatories which proves effective for most patients. Numerous treatment options may be warranted for patients with continued disabling and intractable pain despite temporary treatments or when invasive therapies such as surgical incision, radiofrequency ablation, injected neurotoxin facilitated nerve blocking, implanted nerve stimulator, or surgically decompressing the nerve fail to provide relief. 6, [8] [9] [10] If the condition continues to be refractory, nerve sparing procedures are utilized in preference to neurodestructive surgeries. [11] [12] [13] [14] Neurodestructive procedures, such as neurectomies, are highly invasive and carry some degree of risk of permanent complication. 15, 16 For those patients whose pain recurs following an invasive procedure, a secondary invasive procedure is often contraindicated due to compounding risk. 6 Although occipital neuralgia has been reported to be a complication resulting from frame installation for frame-based radiosurgery, the use of SRS for the treatment of occipital neuralgia has not been reported to date. 17 The success of radiosurgery in the management of trigeminal and glossopharyngeal neuralgia (both cranial-based functional diseases) has been well established. [18] [19] [20] [21] [22] [23] [24] [25] [26] SRS for trigeminal neuralgia and glossopharyngeal neuralgia involves single-fraction high doses to the isocenter placed along the course of the nerve after exiting the central nervous system. In comparison, radiosurgery for occipital neuralgia has not been well explored due to limitations in the ability of traditional SRS treatment modalities in delivering extracranial applications. 27, 28 With the recent advances in intrafractional image guidance, we report here the treatment of occipital neuralgia using linear accelerator-based frameless radiosurgery.
2 | ME TH ODS 2.A | Phantom feasibility study applied by measuring output with film, diode, and a small volume ionization chamber. [29] [30] [31] [32] [33] [34] Relative output factors were obtained from the ratio of the dose at isocenter at depth d max for the conical collimator (4 mm in our case) relative via the "daisy chain" method described by Dieterich et The figure presented here is composed as a simple sagittal illustration so that these points can be emphasized as failure to consider the nonstandard implications of these conclusions could result in coregistration performed to nonrelevant anatomy and possible target miss. The image registration accuracy of both planning and treatment image sets was vital to the successful delivery of this treatment due to the small target size, small beam aperture, and thin imaging slices.
2.B | Case selection
For this case study, a 53-year-old male patient presented with complaints of severe cervical neck pain diagnosed as occipital neuralgia.
The patient had undergone both radiofrequency ablation with 1 month of relief and cervical spine decompression and fusion of C4-7 with no improvement. Various local injections provided only short lasting relief. The pain was reported to be debilitating with the maximum score of V on the Barrow Neurological Institute pain intensity scale. 37 As the occipital neuralgia condition was refractory to radiofrequency ablation, surgery, and medical management, the option of radiosurgery was presented.
2.C | Anatomy, targeting, and immobilization
An extended frameless SRS mask with eight fixation points was fabri- 
3.B | Plan characteristics
The dose grid resolution in the treatment planning system was set to 0.5 mm. For small objects, such as the contoured target, the grid size was automatically adjusted such that at least 10 voxels for each
Image guidance for intrafractional positional corrections during the treatment of occipital neuralgia using a frameless approach requires an inverse approach as compared to traditional cranial-based SRS. Image registration for IGRT during treatment should be performed using anatomy in the vicinity of the target (i.e., on the C1/ C2 level). Other bony anatomy such as the skull, mandible, and the lower C-spine should be understood as capable of moving independent of the target and, therefore, should not be used as registration references when aligning the patient to the isocenter. dimension were included inside the small planning target volume (PTV) or organs-at-risk (OAR) used in the dose algorithm calculation.
At its closest point, the spinal cord was measured to be 12.0 mm from the isocenter. Eighty gray in a single fraction was delivered to the isocenter using 9 mostly ipsilateral 4 mm cone-based arcs with End-to-end testing using this modality was completed during the commissioning of both the linear accelerator and beam model in the treatment planning system used for planning in this study in accordance with current standards of practice. 35, [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] In addition, a separate study performed for this treatment modality characterized the submillimeter congruence of isocentricity of the radiation, mechanical, and image guidance components used for this case study. 39 Due to the target size and location, any linear accelerator attempting to perform SRS for occipital neuralgia would need to undergo specific end-to-end testing with a phantom before treating a patient. Furthermore, during our analysis, couch walkout contributed to a significant degree of incongruence to the radiation-defined isocenter. per IROC analysis. 62 In addition, our clinic has participated and received accreditation from the American College of Radiology and is a Novalis Certified Radiosurgery Center. 63, 64 From the treatment projection map, we determined collision avoidance verification tests are recommended for each patient. This for patient setup IGRT deviating from the generic conclusions of the phantom study as shown in Fig. 2 . As far as the typicality of hardware for patients who could be considered for this treatment, these patients will have likely attempted medical management until this was deemed ineffective, then they would consider nerve-preserving invasive procedures, followed by, with necessity, neurodestructive procedures before they could be referred to SRS. Therefore, the inherent pathway to SRS would likely result in a surgery with a spinal fusion. It is the unique nature of this pathway that has further contributed to the lack of exploration for this treatment site and added novelty to this case study. This study demonstrated that meaningful and accurate IGRT could be performed at the C2 dorsal root ganglion, even with titanium hardware near the vicinity.
Post-treatment delivery analysis, using the results of image guidance determined for each delivered arc, showed minimal deviations from treatment planning projections. The exception to this was the maximum spinal cord dose which was projected to have received a maximum dose of 3.59 AE 0.08 Gy versus the planning calculation dose of 3.36 Gy. This deviation was noted to be well within the acceptable limits asserted by the radiation oncologist.
After treatment of trigeminal neuralgia, SRS is thought to cause axonal degeneration and necrosis, with pain relief after radiosurgery occurring from 2 to 6 weeks after the procedure. 18 A review of three separate case series with validated pain endpoints found that the 1 year pain-free outcome was 69% of patients, dropping to 52% at 3 year. 19 We would propose that larger series of occipital neuralgia patients would likely mirror these results if in fact occipital neuralgia has the same underlying mechanism as trigeminal neuralgia.
We are prospectively following our occipital neuralgia patients and anticipate reporting their outcomes once the sample size is statistically more valid.
Careful image registration for the actual patient was paramount for successful target definition and localization. Registration for anatomy in the cervical spine can be difficult due to the mobilization of the neck and a lack of an ability to share immobilization between diagnostic and therapeutic applications. 65, 66 In addition, limitations of the rigid registration available for use with respect to the target location were noted with the unavailability of a nonrigid registration platform for this study. Such registration must be carried out with a focus on the level of C2 and with careful evaluation of the registration success for both the target-sided dorsal root ganglion and the spinal cord and canal.
| CONCLUSION S
We report the first application of SRS for the treatment of occipital neuralgia. We performed quality assurance testing on the linear accelerator isocentricity, the fusion of planning datasets, and image guidance to ensure accurate delivery. Initial short-term follow-up is encouraging. Additional prospective study is needed before SRS can be considered an appropriate clinical option for occipital neuralgia.
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